Hematology/Oncology · Little Silver, NJ
NPI
1316924772
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
180 White Rd, Suite 101
Little Silver, NJ, 07739
Phone (732) 530-8666
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
221,200 services
Medicare patients, 2024
845
Average age 75
Drug cost, 2024
$2.7M
1,147 prescriptions
Company payments, 2025
$726
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ian C Horkheimer was code J9271 (injection, pembrolizumab, 1 mg), 9,500 times for 16 patients. In total Ian C Horkheimer billed 221,200 services in 155 codes, and Medicare paid $4.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,500 | 16 | $44.64 | $424K |
| J0185 Injection, aprepitant, 1 mg | Office | 9,360 | 22 | $1.24 | $12K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,640 | 13 | $39.46 | $341K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,955 | 14 | $0.08 | $561 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 4,400 | 30 | $15.69 | $69K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,870 | 76 | $0.09 | $345 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 3,792 | 14 | $5.80 | $22K |
| J0897 Injection, denosumab, 1 mg | Office | 2,460 | 18 | $20.81 | $51K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 2,376 | 11 | $20.75 | $49K |
| 85025 Blood Count | Office | 1,995 | 665 | $7.58 | $15K |
| 36415 Venipuncture Blood Collection | Office | 1,646 | 629 | $8.65 | $14K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,590 | 12 | $25.00 | $40K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,520 | 35 | $0.69 | $1,055 |
| 99214 Office E&M - Established | Office | 1,364 | 501 | $102.82 | $140K |
| 96367 Intravenous Infusion, Hydration | Office | 936 | 107 | $23.70 | $22K |
By year: 2022 $3.8M for 212,518 services; 2023 $3.9M for 181,713 services; 2024 $4.4M for 221,200 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,995 | 665 | $7.58 | $15K |
| 36415 Venipuncture Blood Collection | 1,646 | 629 | $8.65 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Ian C Horkheimer prescribed most often to Medicare patients was Anastrozole, with 170 prescriptions and refills. In total Ian C Horkheimer wrote 1,147 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 170 | 420 | 45 | $4,154 |
| Letrozole Generic | 138 | 289 | 32 | $3,187 |
| Eliquis Apixaban | 84 | 132 | 18 | $73K |
| Hydroxyurea Generic | 52 | 104 | 11 | $1,768 |
| Warfarin Sodium Generic | 44 | 96 | Under 11 | $168 |
| Xarelto Rivaroxaban | 41 | 89 | 12 | $48K |
| Imatinib Mesylate Generic | 38 | 38 | Under 11 | $32K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 28 | 28 | 11 | $378 |
| Exemestane Generic | 26 | 39 | Under 11 | $3,139 |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $402K |
| Prednisone Generic | 25 | 37 | 16 | $245 |
| Tamoxifen Citrate Generic | 23 | 52 | Under 11 | $516 |
| Dexamethasone Generic | 21 | 28 | Under 11 | $303 |
| Ibrance Palbociclib | 21 | 21 | Under 11 | $327K |
| Acyclovir Generic | 20 | 30 | Under 11 | $363 |
Brand drugs: 275 claims; generic drugs: 872 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ian C Horkheimer $726 ($726 in general payments such as food, travel and fees) from 7 companies. The largest payer was Abbvie Inc. with $475.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.